Results 11 to 20 of about 31,308 (159)

Myasthenia gravis [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. Ocular weakness with asymmetric ptosis and binocular diplopia is the most typical initial presentation, while early or isolated ...
Juel, Vern C, Massey, Janice M
openaire   +3 more sources

Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis

open access: yesFrontiers in Neurology, 2022
ObjectiveTo investigate the effect of Fufang Huangqi Decoction on the gut microbiota in patients with class I or II myasthenia gravis (MG) and to explore the correlation between gut microbiota and MG (registration number, ChiCTR2100048367; registration ...
Yanghong Chen   +9 more
doaj   +1 more source

Correlation of Prognostic Nutritional Index with Overall Survival of Postoperative Patients with Thymoma

open access: yesZhongliu Fangzhi Yanjiu, 2021
Objective To evaluate the correlation of prognostic nutritional index(PNI) with overall survival of postoperative patients with thymoma. Methods The clinical and pathological data of 173 postoperative patients with thymoma were analyzed retrospectively ...
WANG Yan   +3 more
doaj   +1 more source

HUBUNGAN ANTARA REGULASI EMOSI DENGAN KETABAHAN PADA PENDERITA MYASTHENIA GRAVIS

open access: yesJurnal Empati, 2020
Myasthenia gravis adalah penyakit autoimun yang terjadi ketika zat antibodi yang dibentuk oleh sistem kekebalan tubuh yang seharusnya berfungsi melindungi tubuh justru bekerja melawan jaringan yang ada di tubuhnya sendiri.
Nurmasari Puspita Ningtyas   +1 more
doaj   +1 more source

Myasthenia Gravis [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1903
n ...
openaire   +2 more sources

Clinical features and HLA typing of immune checkpoint inhibitor-associated myasthenia gravis, myocarditis and myositis

open access: yesFrontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICI) have significantly improved the therapeutic outcomes for various malignant tumors, but they may also trigger severe immune-related adverse events (irAEs), such as myositis, myocarditis and myasthenia gravis ...
Xiaoting Lin   +9 more
doaj   +1 more source

MYASTHENIA GRAVIS. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1906
n ...
openaire   +2 more sources

Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population

open access: yesFrontiers in Neurology
Background and purposeMyasthenia gravis (MG) is characterized by fluctuating muscle weakness due to immune-mediated damage to acetylcholine receptors. Viral infections can exacerbate symptoms of muscle weakness, and the clinical status of patients with ...
Peng Liu   +8 more
doaj   +1 more source

Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes

open access: yesOpen Medicine, 2017
Therapeutic options for thymoma-associated myasthenia gravis (MG) patients complicated with hypertension and/or diabetes post thymectomy are often conventional steroids. As the prevalence of diabetes and hypertension globally increases, other therapeutic
Qi Guoyan   +4 more
doaj   +1 more source

Case report: Efgartigimod combined with intravenous methylprednisolone in a case of co-occurrence of unexplained myasthenia gravis, inflammatory myopathy, and fulminant myocarditis

open access: yesFrontiers in Immunology
The co-occurrence of myasthenia gravis (MG), inflammatory myopathy (IM), and fulminant myocarditis (FM) has rarely been reported. The few previous articles were mostly case reports or small sample data analysis, and the etiology was mostly attributed to ...
Hongxia Yang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy